Where does Integrated Biotherapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Integrated Biotherapeutics, Inc. ranks #29,101 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Integrated Biotherapeutics, Inc. hold?

Integrated Biotherapeutics, Inc. holds 9 US utility patents granted between 2015 and 2021, spanning 6 technology areas.

What is Integrated Biotherapeutics, Inc.'s Innovation Score?

Integrated Biotherapeutics, Inc. has an Innovation Score of 27.0 out of 100 (22nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Integrated Biotherapeutics, Inc. focus on?

Integrated Biotherapeutics, Inc.'s top technology area is C07K (Peptides) with 9 patents, ranking #972 of 3,615 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Integrated Biotherapeutics, Inc.'s patent grant rate increasing or decreasing?

Integrated Biotherapeutics, Inc.'s recent grant velocity is -20% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Integrated Biotherapeutics, Inc.'s patents?

Integrated Biotherapeutics, Inc.'s patents average 17.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Integrated Biotherapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Integrated Biotherapeutics, Inc.

USPTO PatentsView assignee record - 9 granted patents across 6 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Integrated ranks #29,101 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 6 technology areas.

#29,101
of 49,997 US assignees by volume: 22nd percentile
by Innovation Score (27.0/100): 17.3
avg claims per patent: -20%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R29101 · US Corporation #29,101 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #29,101/49,997
PHOTO-FINISH Inova Design Solutions
CPC-NARROW C07K · 6 areas
INNOV-THIN 27.0/100
CLAIMS-RICH 17.3 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -20% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Inova Design Solutions Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Integrated’s 27.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.0 pts (30%) Velocity 0.0 pts (0%) Breadth 8.7 pts (32%) Claim depth 10.4 pts (38%)

Qualcomm Incorporated · highest

85
Integrated Biotherap… · this assignee

27
3D Lighting… · lowest

7

What this shows Integrated's Innovation Score is 27.0/100 (22nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Integrated?

Each dot is one of Integrated’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Integrated’s own 17.3 claims/patent is ABOVE the 13.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Integrated vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Integrated's grants concentrate

Integrated Biotherapeutics, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2015. By volume, Integrated sits between Inova Design Solutions Ltd. and Interra Energy Services Ltd..

Inova Design Solu…

9
Instil BIO (UK)

9
Instreamatic

9
Inswave Systems

9
Integrated Micro-…

9
Interactive Fully…

9
Interna B V

9
Interra Energy Se…

9
Integrated Biothe… ◀

9

What this shows Integrated holds 9 patents at rank #29,058, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Integrated

By rank, the assignees closest to #29,058 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Integrated's primary technology class.

Integrated's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 22nd percentile higher than 22% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Integrated Biotherapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	11.1%
2017	1	11.1%
2018	1	11.1%
2019	2	22.2%
2020	1	11.1%
2021	3	33.3%

Which technologies does Integrated Biotherapeutics, Inc. patent most?

C07K - Peptides 9

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

C12Y - Enzymes 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Integrated Biotherapeutics, Inc.'s patent record in context - here's where to go next.

Integrated Biotherapeutics, Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #29,101 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Integrated Biotherapeutics, Inc. against Inova Design Solutions Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.